Durvalumab showed long and durable effects after chemoradiotherapy in stage III non-small cell lung cancer: results of the PACIFIC study
J Thorac Dis
.
2018 Apr;10(Suppl 9):S1108-S1112.
doi: 10.21037/jtd.2018.03.180.
Authors
Takehiro Uemura
1
,
Toyoaki Hida
1
Affiliation
1
Department of Thoracic Oncology, Aichi Cancer Center Hospital, Aichi, Japan.
PMID:
29850190
PMCID:
PMC5949402
DOI:
10.21037/jtd.2018.03.180
No abstract available
Publication types
Editorial
Comment